As of 2026-03-31, 河北常山生化药业's data on the DeepSeek platform in the 医药制造 category shows: The overall mention rate is 0.00%, below the industry average by 15.5 percentage points, with significant room for improvement. The first mention rate is only 0.00%, it is recommended to enhance first-position exposure in AI model responses. Negative mention rate (0.00%) has exceeded positive (0.00%), it is recommended to immediately initiate reputation repair. Among 6 competitors in the same category, 河北常山生化药业's overall mention rate surpasses 0 brands. AIGeo recommends combining the above data to formulate targeted brand monitoring strategies to further enhance brand visibility and reputation in the AI search ecosystem.
河北常山生化药业's Mention Rate is 0.00%, lower than 0.6% of competitors
河北常山生化药业's First Mention is 0.00%, lower than 0.9% of competitors
河北常山生化药业's Preferred Rate is 0.00%, lower than 100.0% of competitors
河北常山生化药业's Positive Rate is 0.00%, lower than 8.9% of competitors
河北常山生化药业's Negative Rate is 0.00%, higher than 96.3% of competitors
| Competitor | Mention Rate | First Mention | Preferred Rate | Positive Rate | Negative Rate | Actions |
|---|---|---|---|---|---|---|
| 百百济神州 | 66.67% | 11.59% | 0% | 59.42% | 1.45% | View Details |
| 中中国生物制药 | 37.68% | 0% | 0% | 26.09% | 0% | View Details |
| 诺诺和诺德 | 34.78% | 0% | 0% | 27.54% | 8.7% | View Details |
| 石石药集团 | 31.88% | 0% | 0% | 18.84% | 1.45% | View Details |
| 艾艾伯维 | 30.43% | 0% | 0% | 28.99% | 1.45% | View Details |
| 阿阿斯利康 | 30.43% | 0% | 0% | 27.54% | 0% | View Details |
| 河河北常山生化药业 (Current Brand) | 0% | 0% | 0% | 0% | 0% | View Details |
